Logo image of IMKTA

INGLES MARKETS INC-CLASS A (IMKTA) Stock Fundamental Analysis

NASDAQ:IMKTA - US4570301048 - Common Stock

70.59 USD
+0.09 (+0.13%)
Last: 9/5/2025, 8:22:32 PM
70.59 USD
0 (0%)
After Hours: 9/5/2025, 8:22:32 PM
Fundamental Rating

4

Overall IMKTA gets a fundamental rating of 4 out of 10. We evaluated IMKTA against 41 industry peers in the Consumer Staples Distribution & Retail industry. Both the profitability and the financial health of IMKTA get a neutral evaluation. Nothing too spectacular is happening here. IMKTA does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

4

1. Profitability

1.1 Basic Checks

In the past year IMKTA was profitable.
In the past year IMKTA had a positive cash flow from operations.
In the past 5 years IMKTA has always been profitable.
IMKTA had a positive operating cash flow in each of the past 5 years.
IMKTA Yearly Net Income VS EBIT VS OCF VS FCFIMKTA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

1.2 Ratios

IMKTA's Return On Assets of 2.22% is in line compared to the rest of the industry. IMKTA outperforms 43.90% of its industry peers.
IMKTA has a Return On Equity of 3.54%. This is in the lower half of the industry: IMKTA underperforms 63.41% of its industry peers.
With a Return On Invested Capital value of 3.80%, IMKTA is not doing good in the industry: 60.98% of the companies in the same industry are doing better.
The Average Return On Invested Capital over the past 3 years for IMKTA is in line with the industry average of 8.38%.
The 3 year average ROIC (10.21%) for IMKTA is well above the current ROIC(3.80%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA 2.22%
ROE 3.54%
ROIC 3.8%
ROA(3y)8.19%
ROA(5y)9.27%
ROE(3y)14.31%
ROE(5y)18.03%
ROIC(3y)10.21%
ROIC(5y)11.79%
IMKTA Yearly ROA, ROE, ROICIMKTA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20 25

1.3 Margins

IMKTA has a Profit Margin (1.05%) which is comparable to the rest of the industry.
IMKTA's Profit Margin has been stable in the last couple of years.
IMKTA has a Operating Margin of 2.10%. This is comparable to the rest of the industry: IMKTA outperforms 51.22% of its industry peers.
In the last couple of years the Operating Margin of IMKTA has declined.
IMKTA has a Gross Margin (23.67%) which is in line with its industry peers.
IMKTA's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 2.1%
PM (TTM) 1.05%
GM 23.67%
OM growth 3Y-23.38%
OM growth 5Y-2.75%
PM growth 3Y-27.97%
PM growth 5Y-0.73%
GM growth 3Y-3.36%
GM growth 5Y-0.61%
IMKTA Yearly Profit, Operating, Gross MarginsIMKTA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20 25

More info and screens

6

2. Health

2.1 Basic Checks

IMKTA has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
Compared to 1 year ago, IMKTA has about the same amount of shares outstanding.
IMKTA has less shares outstanding than it did 5 years ago.
IMKTA has a better debt/assets ratio than last year.
IMKTA Yearly Shares OutstandingIMKTA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M
IMKTA Yearly Total Debt VS Total AssetsIMKTA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

2.2 Solvency

An Altman-Z score of 4.27 indicates that IMKTA is not in any danger for bankruptcy at the moment.
The Altman-Z score of IMKTA (4.27) is comparable to the rest of the industry.
The Debt to FCF ratio of IMKTA is 63.12, which is on the high side as it means it would take IMKTA, 63.12 years of fcf income to pay off all of its debts.
IMKTA's Debt to FCF ratio of 63.12 is on the low side compared to the rest of the industry. IMKTA is outperformed by 75.61% of its industry peers.
IMKTA has a Debt/Equity ratio of 0.32. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of IMKTA (0.32) is better than 60.98% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.32
Debt/FCF 63.12
Altman-Z 4.27
ROIC/WACC0.53
WACC7.15%
IMKTA Yearly LT Debt VS Equity VS FCFIMKTA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.3 Liquidity

IMKTA has a Current Ratio of 3.14. This indicates that IMKTA is financially healthy and has no problem in meeting its short term obligations.
With an excellent Current ratio value of 3.14, IMKTA belongs to the best of the industry, outperforming 95.12% of the companies in the same industry.
IMKTA has a Quick Ratio of 1.53. This is a normal value and indicates that IMKTA is financially healthy and should not expect problems in meeting its short term obligations.
IMKTA has a Quick ratio of 1.53. This is amongst the best in the industry. IMKTA outperforms 92.68% of its industry peers.
Industry RankSector Rank
Current Ratio 3.14
Quick Ratio 1.53
IMKTA Yearly Current Assets VS Current LiabilitesIMKTA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

More info and screens

1

3. Growth

3.1 Past

IMKTA shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -64.71%.
Measured over the past 5 years, IMKTA shows a small growth in Earnings Per Share. The EPS has been growing by 6.65% on average per year.
IMKTA shows a decrease in Revenue. In the last year, the revenue decreased by -7.96%.
The Revenue has been growing slightly by 6.06% on average over the past years.
EPS 1Y (TTM)-64.71%
EPS 3Y-24.13%
EPS 5Y6.65%
EPS Q2Q%-17.37%
Revenue 1Y (TTM)-7.96%
Revenue growth 3Y4.18%
Revenue growth 5Y6.06%
Sales Q2Q%-3.4%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
IMKTA Yearly Revenue VS EstimatesIMKTA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B
IMKTA Yearly EPS VS EstimatesIMKTA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2019 2022 5 10

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 23.85, which indicates a rather expensive current valuation of IMKTA.
IMKTA's Price/Earnings ratio is in line with the industry average.
IMKTA's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 27.06.
Industry RankSector Rank
PE 23.85
Fwd PE N/A
IMKTA Price Earnings VS Forward Price EarningsIMKTA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of IMKTA indicates a somewhat cheap valuation: IMKTA is cheaper than 75.61% of the companies listed in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of IMKTA indicates a slightly more expensive valuation: IMKTA is more expensive than 75.61% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 162.53
EV/EBITDA 6.37
IMKTA Per share dataIMKTA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 50 100 150 200 250

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)3.59
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

6

5. Dividend

5.1 Amount

With a yearly dividend of 0.98%, IMKTA is not a good candidate for dividend investing.
IMKTA's Dividend Yield is a higher than the industry average which is at 1.94.
With a Dividend Yield of 0.98, IMKTA pays less dividend than the S&P500 average, which is at 2.32.
Industry RankSector Rank
Dividend Yield 0.98%

5.2 History

The dividend of IMKTA has a limited annual growth rate of 0.12%.
IMKTA has been paying a dividend for at least 10 years, so it has a reliable track record.
IMKTA has not decreased its dividend for at least 10 years, so it has a reliable track record of non decreasing dividend.
Dividend Growth(5Y)0.12%
Div Incr Years0
Div Non Decr Years11
IMKTA Yearly Dividends per shareIMKTA Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6

5.3 Sustainability

21.75% of the earnings are spent on dividend by IMKTA. This is a low number and sustainable payout ratio.
The dividend of IMKTA is growing, but earnings are growing more, so the dividend growth is sustainable.
DP21.75%
EPS Next 2YN/A
EPS Next 3YN/A
IMKTA Yearly Income VS Free CF VS DividendIMKTA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M
IMKTA Dividend Payout.IMKTA Dividend Payout, showing the Payout Ratio.IMKTA Dividend Payout.PayoutRetained Earnings

More info and screens

INGLES MARKETS INC-CLASS A

NASDAQ:IMKTA (9/5/2025, 8:22:32 PM)

After market: 70.59 0 (0%)

70.59

+0.09 (+0.13%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupConsumer Staples Distribution & Retail
GICS IndustryConsumer Staples Distribution & Retail
Earnings (Last)08-07 2025-08-07/bmo
Earnings (Next)12-26 2025-12-26
Inst Owners93.65%
Inst Owner Change-0.86%
Ins Owners0.08%
Ins Owner Change0%
Market Cap1.34B
Analysts84.44
Price TargetN/A
Short Float %6.88%
Short Ratio8.16
Dividend
Industry RankSector Rank
Dividend Yield 0.98%
Yearly Dividend0.65
Dividend Growth(5Y)0.12%
DP21.75%
Div Incr Years0
Div Non Decr Years11
Ex-Date07-10 2025-07-10 (0.165)
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 23.85
Fwd PE N/A
P/S 0.25
P/FCF 162.53
P/OCF 8
P/B 0.84
P/tB 0.84
EV/EBITDA 6.37
EPS(TTM)2.96
EY4.19%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.43
FCFY0.62%
OCF(TTM)8.82
OCFY12.49%
SpS282.42
BVpS83.93
TBVpS83.93
PEG (NY)N/A
PEG (5Y)3.59
Profitability
Industry RankSector Rank
ROA 2.22%
ROE 3.54%
ROCE 5.02%
ROIC 3.8%
ROICexc 4.47%
ROICexgc 4.47%
OM 2.1%
PM (TTM) 1.05%
GM 23.67%
FCFM 0.15%
ROA(3y)8.19%
ROA(5y)9.27%
ROE(3y)14.31%
ROE(5y)18.03%
ROIC(3y)10.21%
ROIC(5y)11.79%
ROICexc(3y)11.97%
ROICexc(5y)12.99%
ROICexgc(3y)11.97%
ROICexgc(5y)12.99%
ROCE(3y)13.5%
ROCE(5y)15.58%
ROICexcg growth 3Y-23.42%
ROICexcg growth 5Y-0.13%
ROICexc growth 3Y-23.42%
ROICexc growth 5Y-0.13%
OM growth 3Y-23.38%
OM growth 5Y-2.75%
PM growth 3Y-27.97%
PM growth 5Y-0.73%
GM growth 3Y-3.36%
GM growth 5Y-0.61%
F-Score6
Asset Turnover2.11
Health
Industry RankSector Rank
Debt/Equity 0.32
Debt/FCF 63.12
Debt/EBITDA 2.1
Cap/Depr 126.05%
Cap/Sales 2.97%
Interest Coverage 250
Cash Conversion 70.04%
Profit Quality 14.62%
Current Ratio 3.14
Quick Ratio 1.53
Altman-Z 4.27
F-Score6
WACC7.15%
ROIC/WACC0.53
Cap/Depr(3y)141.53%
Cap/Depr(5y)130.04%
Cap/Sales(3y)2.93%
Cap/Sales(5y)2.85%
Profit Quality(3y)57.87%
Profit Quality(5y)73.45%
High Growth Momentum
Growth
EPS 1Y (TTM)-64.71%
EPS 3Y-24.13%
EPS 5Y6.65%
EPS Q2Q%-17.37%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-7.96%
Revenue growth 3Y4.18%
Revenue growth 5Y6.06%
Sales Q2Q%-3.4%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-46.27%
EBIT growth 3Y-20.18%
EBIT growth 5Y3.14%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-88.44%
FCF growth 3Y-32.19%
FCF growth 5Y0.76%
OCF growth 1Y-34.3%
OCF growth 3Y-5.01%
OCF growth 5Y4.42%